MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$3,849K
EPS
-$5.89
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
2,111 2,226* 2,585
Selling, general and administrative expenses
1,951 4,024* 2,298
Loss from operations
-4,062 -6,250* -4,883
Realized gain from sales of trading securities
238 502* 208
Unrealized loss from trading securities
-43 -274* -39
Interest income
22 167* 175
Loss from disposition of property and equipment
-4 --
Total other income
213 395* 344
Net loss
-3,849 -5,855 -4,539
Basic EPS
-5.89 0.309 -0.23
Diluted EPS
-5.89 0.309 -0.23
Basic Average Shares
654,000 -18,977,000 20,155,000
Diluted Average Shares
654,000 -18,977,000 20,155,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Realized gain from salesof trading...$238K Interest income$22K Net loss-$3,849K Total other income$213K Unrealized loss fromtrading securities-$43K Loss fromdisposition of property and...-$4K Loss from operations-$4,062K Research and developmentexpenses$2,111K Selling, general andadministrative expenses$1,951K

enVVeno Medical Corp (NVNO)

enVVeno Medical Corp (NVNO)